Please login or register first to view this content.
Dermatological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA Announces Modifications to iPLEDGE REMS Program
FDA: Needle-Free Devices Should Not Be Used to Inject Dermal Fillers
Infection Risk Does Not Seem to Differ Among Biologics for Psoriasis
COVID-19 Vaccine Concerns ID’d in Psoriasis, Psoriatic Arthritis Patients
Use of Antihypertensive Drugs May Increase Risk for Psoriasis
Sofpironium Bromide Gel Promising for Primary Axillary Hyperhidrosis
Lotrimin, Tinactin Spray Products Recalled Due to Presence of Benzene
Taxane-Containing Chemo Associated With Persistent Alopecia
Opzelura Cream Approved for Atopic Dermatitis
Relatlimab-Nivolumab Fixed-Dose Combo Gets Priority Review for Melanoma
Lexette Approval Expanded to Include Adolescents with Plaque Psoriasis
Isotretinoin Does Not Up Suicide Risk in Acne Patients
Rilzabrutinib Fails in Phase 3 Pemphigus Trial
FDA Clears Neurostimulation Device to Prevent Pressure Injuries
Atopic Dermatitis Improvements Seen in Very Young Treated With Dupilumab
Factors Linked to Development of Pediatric Psoriasis Identified
Korsuva Approved for Chronic Kidney Disease-Associated Pruritus
First Generic Version of Clindagel Gets FDA Approval
